Eshallgo Inc. (Nasdaq: EHGO) announced a 1‑for‑16 reverse stock split of its Class A and Class B ordinary shares, effective at the open of trading on April 20 2026. The consolidation will reduce the number of Class A shares from roughly 26.51 million to about 1.66 million and Class B shares from about 5.86 million to 0.37 million, while keeping total equity value and ownership percentages unchanged.
The reverse split is a compliance measure designed to bring the company’s share price above Nasdaq Capital Market’s minimum bid‑price requirement of $1.00 per share. The company’s share price was $0.20 before the announcement, and the split will raise the per‑share price to approximately $3.20, keeping the market value of the company unchanged.
Shareholders approved the consolidation at the annual general meeting on January 8 2026, authorizing a ratio between 1‑for‑10 and 1‑for‑200. The board of directors approved the specific 1‑for‑16 ratio on April 10 2026. The par value of each ordinary share will increase from $0.0001 to $0.0016, and fractional shares will be rounded to the nearest full share.
Eshallgo has faced repeated Nasdaq bid‑price deficiencies, receiving a deficiency notice in July 2025 and an extension until July 20 2026. The reverse split is intended to pre‑empt a potential delisting by ensuring compliance before the extended deadline. The company’s financial health rating is “WEAK,” and its market capitalization is about $6.73 million, underscoring the need for a compliance action.
While the reverse split does not alter the company’s operations or financial performance, it signals ongoing challenges in maintaining a share price above the regulatory threshold. Investors view such actions as a sign of financial distress, and the announcement was met with a cautious market response.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.